

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | locomotory exploration behavior (GO:0035641) | 5.51271238 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.54461946 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.50409732 |
| 4 | desmosome organization (GO:0002934) | 4.47472600 |
| 5 | vocalization behavior (GO:0071625) | 4.40972259 |
| 6 | synaptic vesicle maturation (GO:0016188) | 4.40350550 |
| 7 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.26115810 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.20006179 |
| 9 | endothelium development (GO:0003158) | 4.18130925 |
| 10 | neuronal action potential propagation (GO:0019227) | 4.05580936 |
| 11 | hemidesmosome assembly (GO:0031581) | 4.01638559 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.01283753 |
| 13 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.00336989 |
| 14 | exploration behavior (GO:0035640) | 3.93663005 |
| 15 | glutamate secretion (GO:0014047) | 3.81340403 |
| 16 | glutamate receptor signaling pathway (GO:0007215) | 3.80376884 |
| 17 | synaptic vesicle exocytosis (GO:0016079) | 3.73496906 |
| 18 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.67261068 |
| 19 | neuron cell-cell adhesion (GO:0007158) | 3.66859615 |
| 20 | cellular potassium ion homeostasis (GO:0030007) | 3.66770559 |
| 21 | sodium ion export (GO:0071436) | 3.59312052 |
| 22 | layer formation in cerebral cortex (GO:0021819) | 3.59301475 |
| 23 | L-amino acid import (GO:0043092) | 3.57231205 |
| 24 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.55405671 |
| 25 | dendritic spine morphogenesis (GO:0060997) | 3.54330161 |
| 26 | synaptic transmission, glutamatergic (GO:0035249) | 3.51490335 |
| 27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.46176328 |
| 28 | transmission of nerve impulse (GO:0019226) | 3.45190771 |
| 29 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.40871738 |
| 30 | neuron recognition (GO:0008038) | 3.35089003 |
| 31 | surfactant homeostasis (GO:0043129) | 3.31335346 |
| 32 | long-term memory (GO:0007616) | 3.29707088 |
| 33 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.29298204 |
| 34 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.27814660 |
| 35 | gamma-aminobutyric acid transport (GO:0015812) | 3.27206401 |
| 36 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.26402602 |
| 37 | protein localization to synapse (GO:0035418) | 3.25567803 |
| 38 | neuron-neuron synaptic transmission (GO:0007270) | 3.25479550 |
| 39 | regulation of synapse structural plasticity (GO:0051823) | 3.23754488 |
| 40 | neurotransmitter secretion (GO:0007269) | 3.20247156 |
| 41 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.18434697 |
| 42 | dendrite morphogenesis (GO:0048813) | 3.16636828 |
| 43 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.13394081 |
| 44 | cerebellar granule cell differentiation (GO:0021707) | 3.12621138 |
| 45 | regulation of synaptic vesicle transport (GO:1902803) | 3.12104869 |
| 46 | axonal fasciculation (GO:0007413) | 3.10138973 |
| 47 | potassium ion import (GO:0010107) | 3.09273051 |
| 48 | cell-substrate junction assembly (GO:0007044) | 3.08332395 |
| 49 | establishment of skin barrier (GO:0061436) | 3.06818963 |
| 50 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.02054186 |
| 51 | regulation of postsynaptic membrane potential (GO:0060078) | 3.00737188 |
| 52 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.00589158 |
| 53 | neuromuscular process controlling balance (GO:0050885) | 2.98461200 |
| 54 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.95580330 |
| 55 | establishment of nucleus localization (GO:0040023) | 2.95362744 |
| 56 | cell communication by electrical coupling (GO:0010644) | 2.94917585 |
| 57 | activation of protein kinase A activity (GO:0034199) | 2.94670509 |
| 58 | positive regulation of synapse maturation (GO:0090129) | 2.93814651 |
| 59 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.92934599 |
| 60 | regulation of synaptic plasticity (GO:0048167) | 2.92633929 |
| 61 | long-term synaptic potentiation (GO:0060291) | 2.92304481 |
| 62 | blood vessel maturation (GO:0001955) | 2.91172290 |
| 63 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.90428138 |
| 64 | positive regulation of membrane potential (GO:0045838) | 2.90338087 |
| 65 | dendritic spine organization (GO:0097061) | 2.88003871 |
| 66 | amino acid import (GO:0043090) | 2.87870760 |
| 67 | regulation of water loss via skin (GO:0033561) | 2.87698185 |
| 68 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.86919900 |
| 69 | positive regulation of Rap GTPase activity (GO:0032854) | 2.85719533 |
| 70 | neuronal ion channel clustering (GO:0045161) | 2.85645131 |
| 71 | proline transport (GO:0015824) | 2.85114324 |
| 72 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.82200123 |
| 73 | chemical homeostasis within a tissue (GO:0048875) | 2.81432388 |
| 74 | lymphangiogenesis (GO:0001946) | 2.81425482 |
| 75 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.81161835 |
| 76 | keratinization (GO:0031424) | 2.80910265 |
| 77 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.78775946 |
| 78 | regulation of ARF protein signal transduction (GO:0032012) | 2.76299812 |
| 79 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.73591220 |
| 80 | glycine transport (GO:0015816) | 2.71425157 |
| 81 | long term synaptic depression (GO:0060292) | 2.70913213 |
| 82 | cellular sodium ion homeostasis (GO:0006883) | 2.70040973 |
| 83 | neurotransmitter transport (GO:0006836) | 2.69990525 |
| 84 | regulation of Rap GTPase activity (GO:0032317) | 2.69532803 |
| 85 | membrane depolarization (GO:0051899) | 2.68884174 |
| 86 | phospholipid translocation (GO:0045332) | 2.68738341 |
| 87 | lipid translocation (GO:0034204) | 2.68738341 |
| 88 | keratinocyte proliferation (GO:0043616) | 2.67421341 |
| 89 | presynaptic membrane assembly (GO:0097105) | 2.66725039 |
| 90 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.66135547 |
| 91 | vesicle transport along microtubule (GO:0047496) | 2.65890675 |
| 92 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.65168349 |
| 93 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.63087947 |
| 94 | nerve growth factor signaling pathway (GO:0038180) | 2.62789903 |
| 95 | regulation of dendritic spine development (GO:0060998) | 2.62666450 |
| 96 | chemosensory behavior (GO:0007635) | 2.61871747 |
| 97 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.61551560 |
| 98 | gap junction assembly (GO:0016264) | 2.61114363 |
| 99 | potassium ion homeostasis (GO:0055075) | 2.60218804 |
| 100 | axon ensheathment in central nervous system (GO:0032291) | 2.59777945 |
| 101 | central nervous system myelination (GO:0022010) | 2.59777945 |
| 102 | membrane depolarization during action potential (GO:0086010) | 2.59299387 |
| 103 | innervation (GO:0060384) | 2.58977929 |
| 104 | membrane hyperpolarization (GO:0060081) | 2.57754778 |
| 105 | presynaptic membrane organization (GO:0097090) | 2.57364232 |
| 106 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.56888099 |
| 107 | synapse organization (GO:0050808) | 2.56644270 |
| 108 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.55099831 |
| 109 | postsynaptic membrane organization (GO:0001941) | 2.53385548 |
| 110 | semaphorin-plexin signaling pathway (GO:0071526) | 2.52763417 |
| 111 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.52640899 |
| 112 | mating behavior (GO:0007617) | 2.52581274 |
| 113 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.52504291 |
| 114 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.51122005 |
| 115 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.50915583 |
| 116 | cell communication involved in cardiac conduction (GO:0086065) | 2.50762571 |
| 117 | suckling behavior (GO:0001967) | 2.50187453 |
| 118 | neuromuscular process controlling posture (GO:0050884) | 2.49433724 |
| 119 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.49393903 |
| 120 | membrane assembly (GO:0071709) | 2.49120859 |
| 121 | synapse assembly (GO:0007416) | 2.49020266 |
| 122 | auditory behavior (GO:0031223) | 2.48943885 |
| 123 | plasma membrane repair (GO:0001778) | 2.48595942 |
| 124 | positive regulation of dendritic spine development (GO:0060999) | 2.48530319 |
| 125 | regulation of neurotransmitter levels (GO:0001505) | 2.48396575 |
| 126 | regulation of vesicle fusion (GO:0031338) | 2.47295861 |
| 127 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.46640323 |
| 128 | organelle transport along microtubule (GO:0072384) | 2.46537322 |
| 129 | adherens junction assembly (GO:0034333) | 2.45264752 |
| 130 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.43795447 |
| 131 | peptide cross-linking (GO:0018149) | 2.42945454 |
| 132 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.42570750 |
| 133 | multicellular organismal water homeostasis (GO:0050891) | 2.42118605 |
| 134 | establishment of endothelial barrier (GO:0061028) | 2.41768471 |
| 135 | cell-substrate adherens junction assembly (GO:0007045) | 2.41509624 |
| 136 | focal adhesion assembly (GO:0048041) | 2.41509624 |
| 137 | lymph vessel development (GO:0001945) | 2.40545482 |
| 138 | clathrin coat assembly (GO:0048268) | 2.38230306 |
| 139 | protein localization to endosome (GO:0036010) | 2.36535013 |
| 140 | Rap protein signal transduction (GO:0032486) | 2.36441617 |
| 141 | regulation of protein polyubiquitination (GO:1902914) | 2.36309737 |
| 142 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.35702346 |
| 143 | renal filtration (GO:0097205) | 2.32489855 |
| 144 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.25805821 |
| 145 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.25800973 |
| 146 | regulation of synapse maturation (GO:0090128) | 2.24956490 |
| 147 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.23343221 |
| 148 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.21853899 |
| 149 | endothelial tube morphogenesis (GO:0061154) | 2.21201320 |
| 150 | morphogenesis of an endothelium (GO:0003159) | 2.21201320 |
| 151 | Notch signaling involved in heart development (GO:0061314) | 2.20424036 |
| 152 | cellular response to epinephrine stimulus (GO:0071872) | 2.19975933 |
| 153 | cell-cell junction assembly (GO:0007043) | 2.18487696 |
| 154 | endocrine hormone secretion (GO:0060986) | 2.18149637 |
| 155 | keratinocyte differentiation (GO:0030216) | 2.18092390 |
| 156 | wound healing, spreading of epidermal cells (GO:0035313) | 2.15743987 |
| 157 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.15496334 |
| 158 | negative regulation of protein localization to cell surface (GO:2000009) | 2.15124052 |
| 159 | labyrinthine layer development (GO:0060711) | 2.14874248 |
| 160 | hippo signaling (GO:0035329) | 2.12867697 |
| 161 | macroautophagy (GO:0016236) | 2.12718345 |
| 162 | cell junction assembly (GO:0034329) | 2.12477633 |
| 163 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.11761641 |
| 164 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.11117256 |
| 165 | regulation of cell communication by electrical coupling (GO:0010649) | 2.11010030 |
| 166 | substrate-dependent cell migration (GO:0006929) | 2.10890882 |
| 167 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.10559406 |
| 168 | peripheral nervous system axon ensheathment (GO:0032292) | 2.09628526 |
| 169 | myelination in peripheral nervous system (GO:0022011) | 2.09628526 |
| 170 | protein targeting to plasma membrane (GO:0072661) | 2.08765045 |
| 171 | nucleus localization (GO:0051647) | 2.08694057 |
| 172 | cardiac conduction (GO:0061337) | 2.08508711 |
| 173 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.07525251 |
| 174 | cardiac muscle cell action potential (GO:0086001) | 2.07522780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.26507515 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.45983320 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.09052095 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.80071026 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.75436250 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.58764299 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.50431397 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.50431397 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.44276923 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.33941704 |
| 11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.33074868 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.29071253 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.25449352 |
| 14 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.22323185 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.21196193 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.19729444 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.08410070 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.05149719 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.01921796 |
| 20 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.96866480 |
| 21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.93404421 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.92782076 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.91978730 |
| 24 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.90918859 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.89456708 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.85985605 |
| 27 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.72080947 |
| 28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.71123227 |
| 29 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.68274105 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.66927291 |
| 31 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.65551698 |
| 32 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.64283521 |
| 33 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.59963572 |
| 34 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.58483418 |
| 35 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.58434389 |
| 36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.56843746 |
| 37 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.51918018 |
| 38 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.51312061 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.51150142 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.48273621 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.47380981 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.46677855 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45213614 |
| 44 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.44668714 |
| 45 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.43635838 |
| 46 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.42650049 |
| 47 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.42650049 |
| 48 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.39587401 |
| 49 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.39495758 |
| 50 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.37383383 |
| 51 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.35972117 |
| 52 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.35791109 |
| 53 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.35707878 |
| 54 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35459556 |
| 55 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.34508315 |
| 56 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.34167131 |
| 57 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.34167131 |
| 58 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.34069209 |
| 59 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.33502557 |
| 60 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.33269803 |
| 61 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.32803147 |
| 62 | TP53_16413492_ChIP-PET_HCT116_Human | 1.32530860 |
| 63 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.32357479 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.31354984 |
| 65 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30653468 |
| 66 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27207824 |
| 67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.26223870 |
| 68 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25664737 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23589792 |
| 70 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.23563173 |
| 71 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.23181817 |
| 72 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.23084742 |
| 73 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.21723824 |
| 74 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.21135533 |
| 75 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.20928578 |
| 76 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.20825897 |
| 77 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.20506355 |
| 78 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.19403999 |
| 79 | CJUN_26792858_Chip-Seq_BT549_Human | 1.18878899 |
| 80 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.18254496 |
| 81 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.18007637 |
| 82 | GATA1_22025678_ChIP-Seq_K562_Human | 1.17663880 |
| 83 | AR_19668381_ChIP-Seq_PC3_Human | 1.17401883 |
| 84 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.16383805 |
| 85 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15706494 |
| 86 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.15460830 |
| 87 | AR_25329375_ChIP-Seq_VCAP_Human | 1.14252603 |
| 88 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.14111941 |
| 89 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13448750 |
| 90 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12194037 |
| 91 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11304934 |
| 92 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.11113063 |
| 93 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.10928858 |
| 94 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.10921659 |
| 95 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.10817610 |
| 96 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.10020220 |
| 97 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.09923294 |
| 98 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.08773607 |
| 99 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.08450008 |
| 100 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08209046 |
| 101 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.07967466 |
| 102 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.07504581 |
| 103 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06692087 |
| 104 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.06645150 |
| 105 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.05399109 |
| 106 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.05193728 |
| 107 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.04719569 |
| 108 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04540768 |
| 109 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.03759773 |
| 110 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.02822364 |
| 111 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02321860 |
| 112 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01966322 |
| 113 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00692335 |
| 114 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00627792 |
| 115 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00159269 |
| 116 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99356331 |
| 117 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.98191069 |
| 118 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.95083850 |
| 119 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94801769 |
| 120 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94602598 |
| 121 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94362344 |
| 122 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.94271658 |
| 123 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94167326 |
| 124 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92901892 |
| 125 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.92525305 |
| 126 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.91718960 |
| 127 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.91172611 |
| 128 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90885097 |
| 129 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90578249 |
| 130 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90350087 |
| 131 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90234532 |
| 132 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90137663 |
| 133 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90084108 |
| 134 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89471734 |
| 135 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.89336066 |
| 136 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.88703580 |
| 137 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88107662 |
| 138 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87687348 |
| 139 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87687348 |
| 140 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.86117321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.97607751 |
| 2 | MP0010368_abnormal_lymphatic_system | 4.85471641 |
| 3 | MP0003880_abnormal_central_pattern | 4.17180293 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.67626065 |
| 5 | MP0004270_analgesia | 3.54077148 |
| 6 | MP0002796_impaired_skin_barrier | 3.08415484 |
| 7 | MP0001879_abnormal_lymphatic_vessel | 2.95562668 |
| 8 | MP0009745_abnormal_behavioral_response | 2.90810965 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.81614736 |
| 10 | MP0002064_seizures | 2.79711277 |
| 11 | MP0005275_abnormal_skin_tensile | 2.76647722 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.73063816 |
| 13 | MP0009046_muscle_twitch | 2.70956442 |
| 14 | MP0003566_abnormal_cell_adhesion | 2.67589354 |
| 15 | MP0002272_abnormal_nervous_system | 2.56420308 |
| 16 | MP0001486_abnormal_startle_reflex | 2.46116341 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.32912453 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.26998119 |
| 19 | MP0001968_abnormal_touch/_nociception | 2.24597827 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.22796680 |
| 21 | MP0003329_amyloid_beta_deposits | 2.17770067 |
| 22 | MP0003950_abnormal_plasma_membrane | 2.16511871 |
| 23 | MP0004885_abnormal_endolymph | 2.12537606 |
| 24 | MP0005423_abnormal_somatic_nervous | 2.11088347 |
| 25 | MP0001501_abnormal_sleep_pattern | 2.09967348 |
| 26 | MP0001440_abnormal_grooming_behavior | 2.07346815 |
| 27 | MP0008569_lethality_at_weaning | 1.98967069 |
| 28 | MP0000383_abnormal_hair_follicle | 1.98071190 |
| 29 | MP0000579_abnormal_nail_morphology | 1.93879946 |
| 30 | MP0005167_abnormal_blood-brain_barrier | 1.86177928 |
| 31 | MP0010352_gastrointestinal_tract_polyps | 1.85103478 |
| 32 | MP0002735_abnormal_chemical_nociception | 1.84079941 |
| 33 | MP0003828_pulmonary_edema | 1.82847340 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.82646048 |
| 35 | MP0000778_abnormal_nervous_system | 1.80571391 |
| 36 | MP0000920_abnormal_myelination | 1.75897415 |
| 37 | MP0004145_abnormal_muscle_electrophysio | 1.74941830 |
| 38 | MP0003091_abnormal_cell_migration | 1.74360635 |
| 39 | MP0002733_abnormal_thermal_nociception | 1.70170015 |
| 40 | MP0005023_abnormal_wound_healing | 1.69918275 |
| 41 | MP0003690_abnormal_glial_cell | 1.67736878 |
| 42 | MP0004858_abnormal_nervous_system | 1.67201650 |
| 43 | MP0002736_abnormal_nociception_after | 1.66545747 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.65836335 |
| 45 | MP0003453_abnormal_keratinocyte_physiol | 1.63360415 |
| 46 | MP0001970_abnormal_pain_threshold | 1.60879697 |
| 47 | MP0002909_abnormal_adrenal_gland | 1.58604230 |
| 48 | MP0004264_abnormal_extraembryonic_tissu | 1.55441274 |
| 49 | MP0002184_abnormal_innervation | 1.49898155 |
| 50 | MP0003633_abnormal_nervous_system | 1.46663868 |
| 51 | MP0004782_abnormal_surfactant_physiolog | 1.46438533 |
| 52 | MP0000751_myopathy | 1.45541018 |
| 53 | MP0005501_abnormal_skin_physiology | 1.41013085 |
| 54 | MP0002098_abnormal_vibrissa_morphology | 1.40094555 |
| 55 | MP0000955_abnormal_spinal_cord | 1.38052970 |
| 56 | MP0002822_catalepsy | 1.37466805 |
| 57 | MP0005623_abnormal_meninges_morphology | 1.37389306 |
| 58 | MP0001177_atelectasis | 1.35521266 |
| 59 | MP0003941_abnormal_skin_development | 1.34897914 |
| 60 | MP0004924_abnormal_behavior | 1.34688126 |
| 61 | MP0005386_behavior/neurological_phenoty | 1.34688126 |
| 62 | MP0002557_abnormal_social/conspecific_i | 1.34260878 |
| 63 | MP0002877_abnormal_melanocyte_morpholog | 1.34187823 |
| 64 | MP0003631_nervous_system_phenotype | 1.32370332 |
| 65 | MP0002066_abnormal_motor_capabilities/c | 1.30891929 |
| 66 | MP0004811_abnormal_neuron_physiology | 1.28404496 |
| 67 | MP0002882_abnormal_neuron_morphology | 1.27530587 |
| 68 | MP0004215_abnormal_myocardial_fiber | 1.26971874 |
| 69 | MP0004484_altered_response_of | 1.25627058 |
| 70 | MP0002837_dystrophic_cardiac_calcinosis | 1.25007070 |
| 71 | MP0000013_abnormal_adipose_tissue | 1.23663784 |
| 72 | MP0003045_fibrosis | 1.23633215 |
| 73 | MP0003632_abnormal_nervous_system | 1.21662215 |
| 74 | MP0004742_abnormal_vestibular_system | 1.21215264 |
| 75 | MP0000377_abnormal_hair_follicle | 1.19219731 |
| 76 | MP0000733_abnormal_muscle_development | 1.18381188 |
| 77 | MP0000537_abnormal_urethra_morphology | 1.18012402 |
| 78 | MP0000767_abnormal_smooth_muscle | 1.15848392 |
| 79 | MP0003279_aneurysm | 1.15112432 |
| 80 | MP0005595_abnormal_vascular_smooth | 1.15099545 |
| 81 | MP0010234_abnormal_vibrissa_follicle | 1.14482459 |
| 82 | MP0004272_abnormal_basement_membrane | 1.14436503 |
| 83 | MP0003634_abnormal_glial_cell | 1.13834097 |
| 84 | MP0003879_abnormal_hair_cell | 1.12391286 |
| 85 | MP0001851_eye_inflammation | 1.10675080 |
| 86 | MP0005076_abnormal_cell_differentiation | 1.09712936 |
| 87 | MP0001216_abnormal_epidermal_layer | 1.08020449 |
| 88 | MP0002060_abnormal_skin_morphology | 1.06247519 |
| 89 | MP0004085_abnormal_heartbeat | 1.05116652 |
| 90 | MP0003191_abnormal_cellular_cholesterol | 1.04999847 |
| 91 | MP0005645_abnormal_hypothalamus_physiol | 1.03793523 |
| 92 | MP0010771_integument_phenotype | 1.03502316 |
| 93 | MP0001348_abnormal_lacrimal_gland | 1.00995240 |
| 94 | MP0005375_adipose_tissue_phenotype | 1.00877972 |
| 95 | MP0004130_abnormal_muscle_cell | 0.99844568 |
| 96 | MP0002229_neurodegeneration | 0.97780841 |
| 97 | MP0005171_absent_coat_pigmentation | 0.97270397 |
| 98 | MP0002152_abnormal_brain_morphology | 0.97051176 |
| 99 | MP0001299_abnormal_eye_distance/ | 0.95434176 |
| 100 | MP0005165_increased_susceptibility_to | 0.94921410 |
| 101 | MP0004043_abnormal_pH_regulation | 0.93066673 |
| 102 | MP0004087_abnormal_muscle_fiber | 0.92956650 |
| 103 | MP0004036_abnormal_muscle_relaxation | 0.92873210 |
| 104 | MP0001502_abnormal_circadian_rhythm | 0.92618511 |
| 105 | MP0001485_abnormal_pinna_reflex | 0.91801742 |
| 106 | MP0008961_abnormal_basal_metabolism | 0.91653598 |
| 107 | MP0002108_abnormal_muscle_morphology | 0.91025383 |
| 108 | MP0000762_abnormal_tongue_morphology | 0.89951780 |
| 109 | MP0000604_amyloidosis | 0.89579509 |
| 110 | MP0005409_darkened_coat_color | 0.89508037 |
| 111 | MP0005666_abnormal_adipose_tissue | 0.89048663 |
| 112 | MP0008438_abnormal_cutaneous_collagen | 0.88226979 |
| 113 | MP0010630_abnormal_cardiac_muscle | 0.86649781 |
| 114 | MP0008874_decreased_physiological_sensi | 0.85967136 |
| 115 | MP0000749_muscle_degeneration | 0.85759428 |
| 116 | MP0003300_gastrointestinal_ulcer | 0.84863606 |
| 117 | MP0004233_abnormal_muscle_weight | 0.84589641 |
| 118 | MP0004510_myositis | 0.84399403 |
| 119 | MP0004084_abnormal_cardiac_muscle | 0.83641409 |
| 120 | MP0005670_abnormal_white_adipose | 0.83119289 |
| 121 | MP0004142_abnormal_muscle_tone | 0.82647426 |
| 122 | MP0003787_abnormal_imprinting | 0.82434058 |
| 123 | MP0000467_abnormal_esophagus_morphology | 0.81991922 |
| 124 | MP0000003_abnormal_adipose_tissue | 0.81812923 |
| 125 | MP0002009_preneoplasia | 0.81364394 |
| 126 | MP0005551_abnormal_eye_electrophysiolog | 0.81297357 |
| 127 | MP0000747_muscle_weakness | 0.81164816 |
| 128 | MP0002925_abnormal_cardiovascular_devel | 0.80759718 |
| 129 | MP0000427_abnormal_hair_cycle | 0.79412097 |
| 130 | MP0002168_other_aberrant_phenotype | 0.79306630 |
| 131 | MP0006276_abnormal_autonomic_nervous | 0.79213392 |
| 132 | MP0002332_abnormal_exercise_endurance | 0.79002697 |
| 133 | MP0006138_congestive_heart_failure | 0.78662946 |
| 134 | MP0005187_abnormal_penis_morphology | 0.77671884 |
| 135 | MP0001784_abnormal_fluid_regulation | 0.77507090 |
| 136 | MP0004947_skin_inflammation | 0.77323324 |
| 137 | MP0003868_abnormal_feces_composition | 0.77304602 |
| 138 | MP0005535_abnormal_body_temperature | 0.76618673 |
| 139 | MP0000569_abnormal_digit_pigmentation | 0.76590656 |
| 140 | MP0000759_abnormal_skeletal_muscle | 0.76047699 |
| 141 | MP0004185_abnormal_adipocyte_glucose | 0.75858181 |
| 142 | MP0002069_abnormal_eating/drinking_beha | 0.75837828 |
| 143 | MP0003137_abnormal_impulse_conducting | 0.75346517 |
| 144 | MP0002295_abnormal_pulmonary_circulatio | 0.74657802 |
| 145 | MP0005620_abnormal_muscle_contractility | 0.74140559 |
| 146 | MP0001905_abnormal_dopamine_level | 0.73789467 |
| 147 | MP0003075_altered_response_to | 0.73027110 |
| 148 | MP0005388_respiratory_system_phenotype | 0.72968274 |
| 149 | MP0002133_abnormal_respiratory_system | 0.72968274 |
| 150 | MP0003283_abnormal_digestive_organ | 0.72456514 |
| 151 | MP0005646_abnormal_pituitary_gland | 0.71232989 |
| 152 | MP0001963_abnormal_hearing_physiology | 0.70955403 |
| 153 | MP0001188_hyperpigmentation | 0.69779771 |
| 154 | MP0004147_increased_porphyrin_level | 0.68319121 |
| 155 | MP0002234_abnormal_pharynx_morphology | 0.65978605 |
| 156 | MP0001958_emphysema | 0.63729660 |
| 157 | MP0010678_abnormal_skin_adnexa | 0.62656944 |
| 158 | MP0001984_abnormal_olfaction | 0.62650089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.92170287 |
| 2 | Myokymia (HP:0002411) | 4.97397295 |
| 3 | Action tremor (HP:0002345) | 4.75516556 |
| 4 | Focal seizures (HP:0007359) | 4.68761544 |
| 5 | Visual hallucinations (HP:0002367) | 4.14742612 |
| 6 | Right ventricular cardiomyopathy (HP:0011663) | 3.88030316 |
| 7 | Atonic seizures (HP:0010819) | 3.87998326 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 3.64674238 |
| 9 | Supranuclear gaze palsy (HP:0000605) | 3.57672780 |
| 10 | Neurofibrillary tangles (HP:0002185) | 3.47665513 |
| 11 | Intention tremor (HP:0002080) | 3.38813570 |
| 12 | Epileptic encephalopathy (HP:0200134) | 3.38617501 |
| 13 | Dysmetria (HP:0001310) | 3.35713432 |
| 14 | Broad-based gait (HP:0002136) | 3.31843353 |
| 15 | Cerebral inclusion bodies (HP:0100314) | 3.30050820 |
| 16 | Scanning speech (HP:0002168) | 3.24888153 |
| 17 | Hyporeflexia of lower limbs (HP:0002600) | 3.11563634 |
| 18 | Febrile seizures (HP:0002373) | 3.10811462 |
| 19 | Insidious onset (HP:0003587) | 3.09569271 |
| 20 | Termporal pattern (HP:0011008) | 3.09569271 |
| 21 | Dysdiadochokinesis (HP:0002075) | 3.08772360 |
| 22 | Absence seizures (HP:0002121) | 3.02363867 |
| 23 | Gaze-evoked nystagmus (HP:0000640) | 2.95856413 |
| 24 | Abnormality of the corticospinal tract (HP:0002492) | 2.92945633 |
| 25 | Arterial tortuosity (HP:0005116) | 2.86151469 |
| 26 | Thick nail (HP:0001805) | 2.85977682 |
| 27 | Hemiplegia (HP:0002301) | 2.84774169 |
| 28 | Overgrowth (HP:0001548) | 2.82032601 |
| 29 | Dialeptic seizures (HP:0011146) | 2.77167042 |
| 30 | Generalized tonic-clonic seizures (HP:0002069) | 2.76023492 |
| 31 | Poor eye contact (HP:0000817) | 2.73758189 |
| 32 | Impaired social interactions (HP:0000735) | 2.68267375 |
| 33 | Abnormal social behavior (HP:0012433) | 2.68267375 |
| 34 | Postural instability (HP:0002172) | 2.66368034 |
| 35 | Hemiparesis (HP:0001269) | 2.63476459 |
| 36 | Subacute progressive viral hepatitis (HP:0006572) | 2.59679825 |
| 37 | Truncal ataxia (HP:0002078) | 2.57845384 |
| 38 | Ankle clonus (HP:0011448) | 2.57158245 |
| 39 | Vascular tortuosity (HP:0004948) | 2.56756334 |
| 40 | Hyperventilation (HP:0002883) | 2.54085927 |
| 41 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.52325442 |
| 42 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.52325442 |
| 43 | Onion bulb formation (HP:0003383) | 2.50369780 |
| 44 | Diplopia (HP:0000651) | 2.49891076 |
| 45 | Abnormality of binocular vision (HP:0011514) | 2.49891076 |
| 46 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.49397947 |
| 47 | Depression (HP:0000716) | 2.48006841 |
| 48 | Ventricular fibrillation (HP:0001663) | 2.46172038 |
| 49 | Cerebral aneurysm (HP:0004944) | 2.41194131 |
| 50 | Abnormal eating behavior (HP:0100738) | 2.39999397 |
| 51 | Excessive salivation (HP:0003781) | 2.39166938 |
| 52 | Drooling (HP:0002307) | 2.39166938 |
| 53 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.38302281 |
| 54 | Osteolytic defects of the hand bones (HP:0009699) | 2.38302281 |
| 55 | Genetic anticipation (HP:0003743) | 2.37884558 |
| 56 | Milia (HP:0001056) | 2.35776877 |
| 57 | Spastic gait (HP:0002064) | 2.35668822 |
| 58 | Anxiety (HP:0000739) | 2.34480253 |
| 59 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.33769847 |
| 60 | Aplasia of the phalanges of the hand (HP:0009802) | 2.33769847 |
| 61 | Aplasia involving bones of the extremities (HP:0009825) | 2.33769847 |
| 62 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.32625907 |
| 63 | Mutism (HP:0002300) | 2.30363663 |
| 64 | Amblyopia (HP:0000646) | 2.29851208 |
| 65 | Increased circulating renin level (HP:0000848) | 2.29831855 |
| 66 | Atrophic scars (HP:0001075) | 2.29807001 |
| 67 | Interstitial pulmonary disease (HP:0006530) | 2.29144508 |
| 68 | Atrioventricular block (HP:0001678) | 2.27640387 |
| 69 | Advanced eruption of teeth (HP:0006288) | 2.27044190 |
| 70 | Aortic aneurysm (HP:0004942) | 2.27037134 |
| 71 | Aqueductal stenosis (HP:0002410) | 2.24397624 |
| 72 | Peripheral hypomyelination (HP:0007182) | 2.23452431 |
| 73 | Difficulty running (HP:0009046) | 2.23270581 |
| 74 | Onycholysis (HP:0001806) | 2.23255873 |
| 75 | Abnormality of nail color (HP:0100643) | 2.19209130 |
| 76 | Alopecia of scalp (HP:0002293) | 2.19118222 |
| 77 | Urinary urgency (HP:0000012) | 2.17518344 |
| 78 | Plantar hyperkeratosis (HP:0007556) | 2.16900523 |
| 79 | Impaired smooth pursuit (HP:0007772) | 2.15207813 |
| 80 | Lower limb muscle weakness (HP:0007340) | 2.14680232 |
| 81 | Abnormality of the lower motor neuron (HP:0002366) | 2.14497932 |
| 82 | Increased connective tissue (HP:0009025) | 2.13656619 |
| 83 | Lower limb amyotrophy (HP:0007210) | 2.13216143 |
| 84 | Distal lower limb amyotrophy (HP:0008944) | 2.11694918 |
| 85 | Dysmetric saccades (HP:0000641) | 2.11143113 |
| 86 | Broad metatarsal (HP:0001783) | 2.10912963 |
| 87 | Hypoplasia of the iris (HP:0007676) | 2.08708309 |
| 88 | Hypotrichosis (HP:0001006) | 2.07846190 |
| 89 | Abnormal atrioventricular conduction (HP:0005150) | 2.07250089 |
| 90 | Ventricular tachycardia (HP:0004756) | 2.06361632 |
| 91 | Hyperkalemia (HP:0002153) | 2.06294796 |
| 92 | Stereotypic behavior (HP:0000733) | 2.06052381 |
| 93 | Broad face (HP:0000283) | 2.05763477 |
| 94 | Protrusio acetabuli (HP:0003179) | 2.04412284 |
| 95 | Short chin (HP:0000331) | 2.04393325 |
| 96 | Palmoplantar hyperkeratosis (HP:0000972) | 2.02239795 |
| 97 | Bundle branch block (HP:0011710) | 2.01495346 |
| 98 | Megalencephaly (HP:0001355) | 1.99297392 |
| 99 | Absent speech (HP:0001344) | 1.98621188 |
| 100 | Progressive inability to walk (HP:0002505) | 1.98143534 |
| 101 | Muscle fiber splitting (HP:0003555) | 1.97926747 |
| 102 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.97594431 |
| 103 | Ankyloglossia (HP:0010296) | 1.96835759 |
| 104 | Heart block (HP:0012722) | 1.95586639 |
| 105 | Acanthosis nigricans (HP:0000956) | 1.94898306 |
| 106 | Fetal akinesia sequence (HP:0001989) | 1.94679035 |
| 107 | Abnormality of secondary sexual hair (HP:0009888) | 1.91400987 |
| 108 | Abnormality of the axillary hair (HP:0100134) | 1.91400987 |
| 109 | Bronchomalacia (HP:0002780) | 1.91269212 |
| 110 | Palmar hyperkeratosis (HP:0010765) | 1.91071404 |
| 111 | Gait ataxia (HP:0002066) | 1.89824242 |
| 112 | Postural tremor (HP:0002174) | 1.88893207 |
| 113 | Absent hand (HP:0004050) | 1.88862258 |
| 114 | Shallow orbits (HP:0000586) | 1.88577592 |
| 115 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.88384313 |
| 116 | Hammertoe (HP:0001765) | 1.88031648 |
| 117 | Visceral angiomatosis (HP:0100761) | 1.87450209 |
| 118 | Esophageal varix (HP:0002040) | 1.87114139 |
| 119 | Prolonged QT interval (HP:0001657) | 1.86930137 |
| 120 | Thyroid-stimulating hormone excess (HP:0002925) | 1.86549921 |
| 121 | Rapidly progressive (HP:0003678) | 1.86111151 |
| 122 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.86006149 |
| 123 | Torticollis (HP:0000473) | 1.85642082 |
| 124 | Absent eyelashes (HP:0000561) | 1.85596815 |
| 125 | Abnormality of the fingertips (HP:0001211) | 1.85196040 |
| 126 | Epileptiform EEG discharges (HP:0011182) | 1.84872321 |
| 127 | Sudden death (HP:0001699) | 1.84172474 |
| 128 | Lower limb asymmetry (HP:0100559) | 1.84083211 |
| 129 | Spontaneous hematomas (HP:0007420) | 1.83928396 |
| 130 | Syncope (HP:0001279) | 1.83843181 |
| 131 | Hypoplastic nipples (HP:0002557) | 1.83036293 |
| 132 | Incomplete penetrance (HP:0003829) | 1.82874866 |
| 133 | Abnormality of the salivary glands (HP:0010286) | 1.81225093 |
| 134 | Lip pit (HP:0100267) | 1.79826118 |
| 135 | Bradykinesia (HP:0002067) | 1.78409162 |
| 136 | Annular pancreas (HP:0001734) | 1.77467508 |
| 137 | Laryngomalacia (HP:0001601) | 1.75403953 |
| 138 | Hemangiomatosis (HP:0007461) | 1.74818555 |
| 139 | Pheochromocytoma (HP:0002666) | 1.74648144 |
| 140 | Cerebral hemorrhage (HP:0001342) | 1.74572506 |
| 141 | Distal lower limb muscle weakness (HP:0009053) | 1.74289128 |
| 142 | Clonus (HP:0002169) | 1.72616249 |
| 143 | EEG with generalized epileptiform discharges (HP:0011198) | 1.72262359 |
| 144 | Striae distensae (HP:0001065) | 1.71919151 |
| 145 | Buphthalmos (HP:0000557) | 1.71864811 |
| 146 | Germ cell neoplasia (HP:0100728) | 1.71591236 |
| 147 | Split foot (HP:0001839) | 1.71453127 |
| 148 | Obstructive sleep apnea (HP:0002870) | 1.70891981 |
| 149 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.70444102 |
| 150 | Alacrima (HP:0000522) | 1.70191232 |
| 151 | Abnormality of salivation (HP:0100755) | 1.69417049 |
| 152 | Neuronal loss in central nervous system (HP:0002529) | 1.69362351 |
| 153 | Metabolic alkalosis (HP:0200114) | 1.68882124 |
| 154 | Fragile nails (HP:0001808) | 1.68627209 |
| 155 | Atrial fibrillation (HP:0005110) | 1.67107076 |
| 156 | Oligodactyly (hands) (HP:0001180) | 1.66526071 |
| 157 | Papilledema (HP:0001085) | 1.66429676 |
| 158 | Abnormality of saccadic eye movements (HP:0000570) | 1.66257724 |
| 159 | Short nail (HP:0001799) | 1.66180006 |
| 160 | Glucose intolerance (HP:0000833) | 1.66115809 |
| 161 | Status epilepticus (HP:0002133) | 1.66057351 |
| 162 | Growth hormone excess (HP:0000845) | 1.65745052 |
| 163 | Bradycardia (HP:0001662) | 1.65418015 |
| 164 | Mitral valve prolapse (HP:0001634) | 1.65209840 |
| 165 | Aneurysm (HP:0002617) | 1.64613744 |
| 166 | Abnormality of oral frenula (HP:0000190) | 1.64552633 |
| 167 | Hypoplasia of dental enamel (HP:0006297) | 1.64089301 |
| 168 | Decreased motor nerve conduction velocity (HP:0003431) | 1.63744232 |
| 169 | Limited hip movement (HP:0008800) | 1.63229079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.77562094 |
| 2 | EPHA4 | 3.41346411 |
| 3 | MST1R | 3.38010107 |
| 4 | LATS1 | 2.93299812 |
| 5 | MAP3K9 | 2.87181004 |
| 6 | MET | 2.58154668 |
| 7 | EPHA2 | 2.24255760 |
| 8 | MARK1 | 2.19775603 |
| 9 | MAP3K4 | 2.17268821 |
| 10 | PAK6 | 2.08396801 |
| 11 | MINK1 | 1.99477613 |
| 12 | DAPK2 | 1.97587069 |
| 13 | STK39 | 1.94152208 |
| 14 | NTRK1 | 1.92269753 |
| 15 | KSR2 | 1.91823961 |
| 16 | PRKD3 | 1.91355903 |
| 17 | TYRO3 | 1.89552208 |
| 18 | TNIK | 1.87472455 |
| 19 | TRPM7 | 1.80570527 |
| 20 | NTRK2 | 1.66334680 |
| 21 | OXSR1 | 1.65811627 |
| 22 | FGFR2 | 1.62266630 |
| 23 | TTN | 1.57010026 |
| 24 | AKT3 | 1.53443188 |
| 25 | RIPK4 | 1.47835214 |
| 26 | RIPK1 | 1.44440658 |
| 27 | MAP2K4 | 1.42942955 |
| 28 | PHKG1 | 1.40526725 |
| 29 | PHKG2 | 1.40526725 |
| 30 | CAMKK1 | 1.39808854 |
| 31 | TIE1 | 1.39302492 |
| 32 | PNCK | 1.37676464 |
| 33 | TGFBR2 | 1.37476326 |
| 34 | CDK5 | 1.37433955 |
| 35 | MAP3K2 | 1.36172053 |
| 36 | CASK | 1.31496002 |
| 37 | CAMK1G | 1.31454514 |
| 38 | STK38 | 1.31321563 |
| 39 | STK38L | 1.30609285 |
| 40 | CDK12 | 1.30582483 |
| 41 | PTK2B | 1.30015037 |
| 42 | EPHB1 | 1.29996906 |
| 43 | PRPF4B | 1.28730075 |
| 44 | MAPK13 | 1.27989047 |
| 45 | EEF2K | 1.27403195 |
| 46 | WNK1 | 1.27367387 |
| 47 | FES | 1.21671344 |
| 48 | KDR | 1.19382149 |
| 49 | MAP2K7 | 1.17872194 |
| 50 | DMPK | 1.11708128 |
| 51 | RET | 1.08119549 |
| 52 | MARK2 | 1.07285449 |
| 53 | TRIB3 | 1.07134139 |
| 54 | LMTK2 | 1.06370722 |
| 55 | PAK3 | 1.06201174 |
| 56 | SGK223 | 1.05516705 |
| 57 | SGK494 | 1.05516705 |
| 58 | CAMK2B | 1.05261346 |
| 59 | CAMKK2 | 1.02287192 |
| 60 | FGFR3 | 0.99441977 |
| 61 | CAMK2A | 0.99392127 |
| 62 | FER | 0.99021675 |
| 63 | WNK4 | 0.98872571 |
| 64 | PINK1 | 0.98626923 |
| 65 | PKN1 | 0.98396718 |
| 66 | GRK5 | 0.97055288 |
| 67 | JAK1 | 0.95089505 |
| 68 | MAP3K13 | 0.94995222 |
| 69 | KSR1 | 0.94546449 |
| 70 | PRKCH | 0.94501252 |
| 71 | FGFR4 | 0.93975058 |
| 72 | UHMK1 | 0.93695855 |
| 73 | STK11 | 0.92849302 |
| 74 | MAP3K7 | 0.92323963 |
| 75 | MAPK7 | 0.87726519 |
| 76 | CAMK1 | 0.87411470 |
| 77 | PLK2 | 0.87229517 |
| 78 | EPHB2 | 0.85899003 |
| 79 | MAP3K12 | 0.84135639 |
| 80 | PRKCG | 0.83978624 |
| 81 | SIK2 | 0.83505917 |
| 82 | ROCK2 | 0.82656959 |
| 83 | PDPK1 | 0.82440116 |
| 84 | SGK1 | 0.80064084 |
| 85 | PDGFRA | 0.76984715 |
| 86 | DAPK1 | 0.76888952 |
| 87 | CAMK2D | 0.73865257 |
| 88 | PDK1 | 0.73858987 |
| 89 | FGR | 0.71634366 |
| 90 | MTOR | 0.70981406 |
| 91 | TGFBR1 | 0.70303480 |
| 92 | STK24 | 0.69567093 |
| 93 | PRKCE | 0.68648775 |
| 94 | CAMK1D | 0.68270570 |
| 95 | INSRR | 0.66293220 |
| 96 | MAP3K6 | 0.65699724 |
| 97 | LATS2 | 0.65252331 |
| 98 | CDC42BPA | 0.64319078 |
| 99 | PDGFRB | 0.64103295 |
| 100 | MAPKAPK5 | 0.63297868 |
| 101 | MELK | 0.63112158 |
| 102 | PTK2 | 0.61928888 |
| 103 | SGK3 | 0.61506651 |
| 104 | NEK6 | 0.61208071 |
| 105 | CSNK1G2 | 0.60843498 |
| 106 | SGK2 | 0.60234570 |
| 107 | ALK | 0.60104551 |
| 108 | BCR | 0.59444272 |
| 109 | PRKD1 | 0.58591666 |
| 110 | FYN | 0.58476713 |
| 111 | ICK | 0.58098002 |
| 112 | NLK | 0.57322677 |
| 113 | DYRK1A | 0.54174879 |
| 114 | CAMK4 | 0.53759555 |
| 115 | MAP3K1 | 0.51771385 |
| 116 | RPS6KA3 | 0.51645401 |
| 117 | ITK | 0.51604095 |
| 118 | CAMK2G | 0.50920142 |
| 119 | CSK | 0.50016854 |
| 120 | CDK14 | 0.49038811 |
| 121 | DDR2 | 0.48419208 |
| 122 | PRKAA2 | 0.48040791 |
| 123 | ROCK1 | 0.47583174 |
| 124 | MYLK | 0.47086286 |
| 125 | MAPK10 | 0.46584563 |
| 126 | CDK15 | 0.46233442 |
| 127 | MAPK12 | 0.45976676 |
| 128 | BMX | 0.45826334 |
| 129 | PTK6 | 0.45617256 |
| 130 | WNK3 | 0.44437802 |
| 131 | RPS6KA2 | 0.43886727 |
| 132 | BMPR2 | 0.43245391 |
| 133 | MAP2K1 | 0.42778946 |
| 134 | EPHA3 | 0.42081191 |
| 135 | MAP3K3 | 0.39469254 |
| 136 | OBSCN | 0.38729876 |
| 137 | FGFR1 | 0.38531496 |
| 138 | ZAP70 | 0.38073598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.92292116 |
| 2 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.46335635 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.41440303 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.34173920 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.30363792 |
| 6 | Salivary secretion_Homo sapiens_hsa04970 | 2.18773947 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.18696530 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.06133148 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.02203078 |
| 10 | Adherens junction_Homo sapiens_hsa04520 | 2.00435381 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 1.95794888 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.94575362 |
| 13 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.93329389 |
| 14 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.81331057 |
| 15 | Long-term depression_Homo sapiens_hsa04730 | 1.81196406 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.75872126 |
| 17 | Olfactory transduction_Homo sapiens_hsa04740 | 1.74708430 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.72109615 |
| 19 | Renin secretion_Homo sapiens_hsa04924 | 1.69861104 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.68936548 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.68000565 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.58944733 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.56855358 |
| 24 | Taste transduction_Homo sapiens_hsa04742 | 1.56165160 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.49244452 |
| 26 | Axon guidance_Homo sapiens_hsa04360 | 1.46834717 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.43405004 |
| 28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.42831176 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.38890421 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.38882319 |
| 31 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.30332095 |
| 32 | Gap junction_Homo sapiens_hsa04540 | 1.28208921 |
| 33 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.27707725 |
| 34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.27655937 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26063342 |
| 36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.25928466 |
| 37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.19910270 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.18389007 |
| 39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.17629252 |
| 40 | Cocaine addiction_Homo sapiens_hsa05030 | 1.14488971 |
| 41 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.14239135 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.11637648 |
| 43 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.10870061 |
| 44 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.10701190 |
| 45 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.08770652 |
| 46 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.08674081 |
| 47 | Thyroid cancer_Homo sapiens_hsa05216 | 1.07632746 |
| 48 | Glioma_Homo sapiens_hsa05214 | 1.05537210 |
| 49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.04512402 |
| 50 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.00353514 |
| 51 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.98591541 |
| 52 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.98079336 |
| 53 | Melanogenesis_Homo sapiens_hsa04916 | 0.95941649 |
| 54 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.95084191 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.92198296 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90401632 |
| 57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89802341 |
| 58 | Histidine metabolism_Homo sapiens_hsa00340 | 0.87635557 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86173683 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.84637247 |
| 61 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.82746365 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81541425 |
| 63 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.79764112 |
| 64 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.79561325 |
| 65 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.79312612 |
| 66 | Bile secretion_Homo sapiens_hsa04976 | 0.75681172 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.75524868 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73972177 |
| 69 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.73699419 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.72595402 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71895595 |
| 72 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.71673294 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70827245 |
| 74 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.70521686 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70201066 |
| 76 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.69767821 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69279726 |
| 78 | Pathways in cancer_Homo sapiens_hsa05200 | 0.69213316 |
| 79 | Tight junction_Homo sapiens_hsa04530 | 0.69110533 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68924046 |
| 81 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.67199456 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.66607612 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66449460 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.66092087 |
| 85 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.65890456 |
| 86 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.65762907 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65009030 |
| 88 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64586348 |
| 89 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.63862841 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63648590 |
| 91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.62552778 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58578783 |
| 93 | Focal adhesion_Homo sapiens_hsa04510 | 0.58459656 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57566167 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57033340 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.56936968 |
| 97 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55639141 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52871071 |
| 99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52645877 |
| 100 | Platelet activation_Homo sapiens_hsa04611 | 0.51874970 |
| 101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50614656 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49974071 |
| 103 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.48409239 |
| 104 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.48130835 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | 0.48095813 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47838214 |
| 107 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44200082 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43198640 |
| 109 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.42512691 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42009446 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | 0.40826716 |
| 112 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.39790088 |
| 113 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39152416 |
| 114 | Phototransduction_Homo sapiens_hsa04744 | 0.38512845 |
| 115 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.37688180 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37065098 |
| 117 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36670581 |
| 118 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36354423 |
| 119 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35608022 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34877861 |
| 121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.33082315 |

